0 28/02/2022 2022-02-28 false false false false false false false false false false true false false true false false false false false true false No description of principal activities is disclosed 2021-03-01 Sage Accounts Production 2020 Update 1 - FRS102_2019 xbrli:pure xbrli:shares iso4217:GBP 06496168 2021-03-01 2022-02-28 06496168 2022-02-28 06496168 2020-03-01 2021-02-28 06496168 2021-02-28 06496168 2020-02-29 06496168 bus:RegisteredOffice 2021-03-01 2022-02-28 06496168 bus:LeadAgentIfApplicable 2021-03-01 2022-02-28 06496168 bus:Director1 2021-03-01 2022-02-28 06496168 bus:CompanySecretary1 2021-03-01 2022-02-28 06496168 core:WithinOneYear 2022-02-28 06496168 core:WithinOneYear 2021-02-28 06496168 core:RetainedEarningsAccumulatedLosses 2020-03-01 2021-02-28 06496168 core:RetainedEarningsAccumulatedLosses 2021-03-01 2022-02-28 06496168 core:ShareCapital 2022-02-28 06496168 core:ShareCapital 2021-02-28 06496168 core:RetainedEarningsAccumulatedLosses 2022-02-28 06496168 core:RetainedEarningsAccumulatedLosses 2021-02-28 06496168 core:ShareCapital 2020-02-29 06496168 core:RetainedEarningsAccumulatedLosses 2020-02-29 06496168 core:CostValuation core:Non-currentFinancialInstruments 2022-02-28 06496168 core:Non-currentFinancialInstruments 2022-02-28 06496168 core:Non-currentFinancialInstruments 2021-02-28 06496168 bus:Director1 2021-02-28 06496168 bus:Director1 2022-02-28 06496168 bus:Director1 2020-02-29 06496168 bus:Director1 2021-02-28 06496168 bus:Director1 2020-03-01 2021-02-28 06496168 bus:SmallEntities 2021-03-01 2022-02-28 06496168 bus:AuditExemptWithAccountantsReport 2021-03-01 2022-02-28 06496168 bus:FullAccounts 2021-03-01 2022-02-28 06496168 bus:SmallCompaniesRegimeForAccounts 2021-03-01 2022-02-28 06496168 bus:PrivateLimitedCompanyLtd 2021-03-01 2022-02-28
Company registration number: 06496168
Ergo Flex Enterprises Ltd
Unaudited filleted financial statements
28 February 2022
Ergo Flex Enterprises Ltd
Contents
Directors and other information
Accountants report
Statement of financial position
Statement of changes in equity
Notes to the financial statements
Ergo Flex Enterprises Ltd
Directors and other information
Director Gerald Joseph MacEwan
Secretary Margaret MacEwan
Company number 06496168
Registered office 246 Park View
Whitley Bay
Tyne and Wear
NE26 3QX
Business address 246 Park View
Whitley Bay
Tyne and Wear
NE26 3QX
Accountants Harrison Hutchinson Ltd
246 Park View
Whitley Bay
Tyne and Wear
NE26 3QX
Ergo Flex Enterprises Ltd
Chartered accountants report to the director on the preparation of the
unaudited statutory financial statements of Ergo Flex Enterprises Ltd
Year ended 28th February 2022
In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Ergo Flex Enterprises Ltd for the year ended 28th February 2022 which comprise the statement of financial position, statement of changes in equity and related notes from the company's accounting records and from information and explanations you have given us.
As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed at http://www.icaew.com /en/members/regulations-standards-and-guidance/.
This report is made solely to the director of Ergo Flex Enterprises Ltd, as a body, in accordance with the terms of our engagement letter. Our work has been undertaken solely to prepare for your approval the financial statements of Ergo Flex Enterprises Ltd and state those matters that we have agreed to state to them, as a body, in this report in accordance with ICAEW Technical Release 07/16 AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Ergo Flex Enterprises Ltd and its director as a body for our work or for this report.
It is your duty to ensure that Ergo Flex Enterprises Ltd has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of Ergo Flex Enterprises Ltd. You consider that Ergo Flex Enterprises Ltd is exempt from the statutory audit requirement for the year.
We have not been instructed to carry out an audit or a review of the financial statements of Ergo Flex Enterprises Ltd. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.
Harrison Hutchinson Ltd
Chartered Accountants
246 Park View
Whitley Bay
Tyne and Wear
NE26 3QX
Ergo Flex Enterprises Ltd
Statement of financial position
28th February 2022
2022 2021
Note £ £ £ £
Fixed assets
Investments 3 2 2
_______ _______
2 2
Current assets
Debtors 4 662,469 699,595
Cash at bank and in hand 2,564,913 2,379,396
_________ _________
3,227,382 3,078,991
Creditors: amounts falling due
within one year 5 ( 1,755) ( 143,569)
_______ _______
Net current assets 3,225,627 2,935,422
_________ _________
Total assets less current liabilities 3,225,629 2,935,424
_________ _________
Net assets 3,225,629 2,935,424
_________ _________
Capital and reserves
Called up share capital 2 2
Profit and loss account 3,225,627 2,935,422
_________ _________
Shareholders funds 3,225,629 2,935,424
_________ _________
For the year ending 28 February 2022 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476;
- The director acknowledges their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of comprehensive income has not been delivered.
These financial statements were approved by the board of directors and authorised for issue on 27 July 2022 , and are signed on behalf of the board by:
Gerald Joseph MacEwan
Director
Company registration number: 06496168
Ergo Flex Enterprises Ltd
Statement of changes in equity
Year ended 28th February 2022
Called up share capital Profit and loss account Total
£ £ £
At 1st March 2020 2 2,674,931 2,674,933
Profit for the year 510,491 510,491
_______ _______ _______
Total comprehensive income for the year - 510,491 510,491
Dividends paid and payable ( 250,000) ( 250,000)
_______ _______ _______
Total investments by and distributions to owners - ( 250,000) ( 250,000)
_______ _________ _________
At 28th February 2021 and 1st March 2021 2 2,935,422 2,935,424
Profit for the year 550,205 550,205
_______ _______ _______
Total comprehensive income for the year - 550,205 550,205
Dividends paid and payable ( 260,000) ( 260,000)
_______ _______ _______
Total investments by and distributions to owners - ( 260,000) ( 260,000)
_______ _________ _________
At 28th February 2022 2 3,225,627 3,225,629
_______ _________ _________
Ergo Flex Enterprises Ltd
Notes to the financial statements
Year ended 28th February 2022
1. Statement of compliance
These financial statements have been prepared in compliance with the provisions of FRS 102, Section 1A, 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'. The Triennial review 2017 amendments to the standard have been early adopted.
2. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Taxation
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in the statement of comprehensive income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves. In this case, tax is recognised in other comprehensive income or directly in capital and reserves, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Fixed asset investments
Fixed asset investments are initially recorded at cost, and subsequently stated at cost less any accumulated impairment losses. Listed investments are measured at fair value with changes in fair value being recognised in profit or loss.
Impairment
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. When it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that are largely independent of the cash inflows from other assets or groups of assets.
Financial instruments
A financial asset or a financial liability is recognised only when the company becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Debt instruments are subsequently measured at amortised cost. Where investments in non-convertible preference shares and non-puttable ordinary shares or preference shares are publicly traded or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value with changes in fair value recognised in profit or loss. All other such investments are subsequently measured at cost less impairment. Other financial instruments, including derivatives, are initially recognised at fair value, unless payment for an asset is deferred beyond normal business terms or financed at a rate of interest that is not a market rate, in which case the asset is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Other financial instruments are subsequently measured at fair value, with any changes recognised in profit or loss, with the exception of hedging instruments in a designated hedging relationship.
Financial assets that are measured at cost or amortised cost are reviewed for objective evidence of impairment at the end of each reporting date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. For all equity instruments regardless of significance, and other financial assets that are individually significant, these are assessed individually for impairment. Other financial assets are either assessed individually or grouped on the basis of similar credit risk characteristics. Any reversals of impairment are recognised in profit or loss immediately, to the extent that the reversal does not result in a carrying amount of the financial asset that exceeds what the carrying amount would have been had the impairment not previously been recognised.
3. Investments
Shares in group undertakings and participating interests Total
£ £
Cost
At 1st March 2021 and 28th February 2022 2 2
_______ _______
Impairment
At 1st March 2021 and 28th February 2022 - -
_______ _______
Carrying amount
At 28th February 2022 2 2
_______ _______
At 28th February 2021 2 2
_______ _______
4. Debtors
2022 2021
£ £
Amounts owed by group undertakings and undertakings in which the company has a participating interest 72,012 -
Other debtors 590,457 699,595
_______ _______
662,469 699,595
_______ _______
5. Creditors: amounts falling due within one year
2022 2021
£ £
Amounts owed to group undertakings and undertakings in which the company has a participating interest - 135,835
Corporation tax 1,090 7,069
Other creditors 665 665
_______ _______
1,755 143,569
_______ _______
6. Directors advances, credits and guarantees
During the year the director entered into the following advances and credits with the company:
2022
Balance brought forward Advances /(credits) to the director Amounts repaid Balance o/standing
£ £ £ £
Gerald Joseph MacEwan 551,633 150,862 ( 260,000) 442,495
_______ _______ _______ _______
2021
Balance brought forward Advances /(credits) to the director Amounts repaid Balance o/standing
£ £ £ £
Gerald Joseph MacEwan 718,764 82,869 ( 250,000) 551,633
_______ _______ _______ _______
7. Related party transactions
During the year the company entered into the following transactions with related parties:
Transaction value
2022 2021
£ £
Dividends to directors 130,000 125,000
_______ _______
Ordinary dividends are paid to the director in his capacity as shareholder.